|
|
|||
|
||||
OverviewA diagnosis of choroideremia once predicted a history of gradual vision loss. Dedicated doctors and researchers like Ian MacDonald are determined to change that, raising money for research, and exploring and testing possible treatments. Our Hope for Gene Therapy traces developments in eye genetics and our understanding of choroideremia, an inherited retinal disorder. The span of Dr. MacDonald's career, led to the first-in-Canada test of an experimental gene therapy to halt its progression in 2015. Nothing about the experiment was simple-but it taught Dr. MacDonald and his team a great deal and laid the foundations of future possibilities for choroideremia patients around the world. Infused with humanity and personal experiences, Our Hope for Gene Therapy examines a possible future treatment for vision loss. Full Product DetailsAuthor: Ian M MacDonaldPublisher: FriesenPress Imprint: FriesenPress Dimensions: Width: 14.00cm , Height: 1.30cm , Length: 21.60cm Weight: 0.322kg ISBN: 9781038357830ISBN 10: 1038357837 Pages: 162 Publication Date: 22 April 2026 Audience: General/trade , General Format: Hardback Publisher's Status: Active Availability: Available To Order We have confirmation that this item is in stock with the supplier. It will be ordered in for you and dispatched immediately. Table of ContentsReviewsAuthor InformationDr. Ian M. MacDonald received the Founders Award of the Canadian College of Medical Geneticists for his long career in eye genetics. An ophthalmologist and a researcher, Dr. MacDonald hopes to make his work accessible beyond scientific journals-to choroideremia patients and their families around the world. Dr. MacDonald is Director and Chair Suzanne Véronneau-Troutman, MD, FRCSC, FACS, Department of Ophthalmology, Faculty of Medicine, University of Montreal. Tab Content 6Author Website:Countries AvailableAll regions |
||||